Date Added: Sep 2009
Recent supply chain history can be summarized as follows: rising costs + domestic market saturation = pressure to globalize operations. But the implications of this seemingly tidy equation are anything but simple. After a frenetic burst of global expansion, Life Sciences companies are pausing to ask questions like: "Is this really worth the risk?", "What can we do to combat counterfeiting and contamination?", and "How do all of the segments within Life Sciences Industry manage an increasingly complex supply chain?" The supply chain has historically been an underutilized vehicle for increasing a company's value, but when delivery to market is quicker, safer and more efficient, the benefit to enhancing this capability can be immediately realized and, in some cases, commercialized.